New strategies for surgical management of ischemic cardiomyopathy

Expert Review of Cardiovascular Therapy

Volumn 6, Issue 4, 2008, Pages 521-530

  Ailawadi, Gorav ^a   Kron, Irving L ^b  

^a TCV Surgery   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Coronary artery bypass heart; Failure; Ischemic cardiomyopathy; Left ventricular assist device; Left ventricular reconstruction; Left ventricular remodeling; Mitral repair; Stem cells; Ventricular restraint device

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEARTMATE XVE; UNCLASSIFIED DRUG;

ARTIFICIAL HEART; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL OXYGENATION; HEART ASSIST DEVICE; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MITRAL VALVE REPAIR; PATHOPHYSIOLOGY; PATIENT SAFETY; REVIEW; STEM CELL TRANSPLANTATION; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; HEART VENTRICLE REMODELING; METHODOLOGY; UNITED STATES;

CARDIAC SURGICAL PROCEDURES; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MYOCARDIAL ISCHEMIA; STEM CELL TRANSPLANTATION; UNITED STATES; VENTRICULAR REMODELING;

EID: 43049154889     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.6.4.521     Document Type: Review

References (64)

1. Rosamond W, Flegal K, Friday G et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115(5), e69-e171 (2007).
2. Jessup M, Brozena S. Heart Failure. N. Engl. J. Med. 348, 2007 (2003).
3. Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J. Am. Coll. Cardiol. 39, 210-218 (2002).
4. Mackay J, Mensah GA. The at last of heart disease and stroke In: World Health Organization. First Edition. Geneva, Switzerland, 1-112 (2004).
5. Yancy CW. Comprehensive treatment of heart failure: state of the art medical therapy. Rev. Cardiovasc. Med. 6(Suppl. 2), 43 (2005).
6. Levy D, Kenchaiah S, Larson MG et al. Long term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347, 1397 (2002).
7. Ahmed A, Aronow WS, Fleg JL. Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am. Heart J. 151, 444-450 (2006).
8. Singh RR, Lisle RC, Kron IL. Surgical treatment of the failing heart. Minerva Cardioangiol. 53, 287-297 (2005).
9. Wellnhofer E, Olariu A, Klein C. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 109(18), 2172-2174 (2004).
10. Goldstein DJ, Smego D, Michler RE. Surgical aspects of congestive heart failure. Heart Fail. Rev. 11(2), 171-192 (2006).
11. Taylor DO, Edwards LB, Boucek MM et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report - 2007. J. Heart Lung Transplant. 26(8), 769-781 (2007).
12. Aziz T, Burgess M, Rahman AN et al. Cardiac transplantation for cardiomyopathy and ischemic heart disease, differences in outcome up to 10 years. J. Heart Lung Transplant. 20(5), 525-533 (2001).
13. Phillips HR, O'Connor CM. Revasc for heart failure. Am. Heart J. 153. 65-73 (2007).
14. Chareonthaitawee P, Gersh BP, Araoz PA et al. Revascularization in severe left ventricular dysfunction: the role of viability testing. J. Am. Coll. Cardiol. 46(4), 567-74 (2005).
15. Bax JJ, Visser FC, Poldermans D et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation. 104(12 Suppl. 1), 1314-1318 (2001).
16. Carluccio E, Biagioloi P, Alunni G et al. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J. Am. Coll. Cardiol. 47(5), 969-977 (2006).
17. Allman KC, Shaw LJ, Hachamovitch R et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J. Am. Coll. Cardiol. 39(7), 1151-1158 (2002).
18. Bourque JM, Velazquez EJ, Borges-Neto S et al. Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis. Am. Heart J. 146, 621-627 (2003).
19. Hunt SA, Abrahan WT, Chin H et al. 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J. Am. Coll. Cardiol. 46(6), e1-e82 (2005).
20. Eagle KA, Guyton RA, Davidoff R et al. ACC/AHA guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/American heart task force (2004).
21. Tarakji KG, Brunken R, McCarthy PM et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation 113, 230-237 (2006).
22. Doenst T, Velazquez EJ, Beyersdurf F et al. To STICH or not to STICH: we know the answer, but do we understand the question? J. Thorac. Cardiovasc. Surg. 129(2), 246-249 (2005).
23. Cleland JG, Freemantle N, Ball SG et al. Coronary stenting in patients with depressed left ventricular function: acute and long-term results in a selected population. Catheter Cardiovasc. Interv. 59, 429-433 (2003).
24. Beanlands R, Nichol G, Ruddy TD et al. Evaluation of outcome and cost effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rational, design, and methods. Control Clin. Trials 24, 776-794 (2003).
25. Baldasseroni S, Opasich C, Gorini M et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am. Heart J. 143, 398-405 (2002).
26. Patel JB, Borgeson DD, Barnes ME et al. Mitral regurgitation in patients with advanced systolic heart failure. J. Card. Fail. 10(4), 285-291 (2004).
27. Sarris GE, Cahill PD, Hansen DE et al. Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction. J. Thorac. Cardiovasc. Surg. 95(6), 969-979 (1988).
28. Borger MA, Alam A, Murphy PM et al. Chronic ischemic mitral regurgitation: repair, replace or rethink? Ann. Thorac. Surg. 81(3), 1153-1161 (2006).
29. Zeltsman D, Acker MA. Surgical management of heart failure. an overview. Annu. Rev. Med. 53, 383-391 (2002).
30. Badhwar V, Boiling SF. Mitral valve surgery in the patient with left ventricular dysfunction. Semin. Thorac. Cardiovasc. Surg. 14, 133-136 (2002).
31. Gangemi JJ, Tribble CG, Ross SD et al. Does the additive risk of mitral valve repair in patients with ischemic cardiomyopathy prohibit surgical intervention? Ann. Surg. 231(5), 710-714 (2000).
32. Di Donato M, Sabatier M, Dor V et al. Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery. J. Thorac. Cardiovasc. Surg. 121(1), 91-96 (2001).
33. Athanasuleas CL, Buckberg GD, Stanley AW et al. Ventricular restoration in the treatment ofcongestive heart failure due to post-infraction ventricular dilation. J. Am. Coll. Cardiol. 44(7), 1439-1445 (2004).
34. Menicanti L, Castelvecchio S, Ranucci M et al. Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration. J. Thorac. Cardiovasc. Surg. 134(2), 433-441 (2007).
35. Kaza AK, Patel MR, Fiser SM et al. Ventricular reconstruction results in improved left ventricular function and amelioration of mitral insufficiency. Ann. Surg. 235(6), 828-832 (2002).
36. Adams JD, Fedoruk LM, Tache-Leon CA, et al. Does preoperative ejection fraction predict operative mortality with left ventricular restoration? Ann. Thorac. Surg. 82(5), 1715-1719 (2006).
37. Fedoruk LM, Tribble CG, Kern JA etal. Predicting Operative Mortality After surgery for Ischemic Cardiomyopathy. Ann. Thorac. Surg. 83, 2029-2035 (2007).
38. Cope JT, Kaza AK, Reade CC et al. A cost comparison of heart transplantation versus alternative operations for cardiomyopathy. Ann. Thorac. Surg. 72(4), 1298-305 (2001).
39. Left ventricular aneurysm. In: Kirklin/Barratt-Boyes Cardiac Surgery. Third Edition. Kouchoukos NT, Blackstone EH, Doty DB, Hanley FL, Karp RB (Eds). Elsevier Publishers, PA, USA 437-455 (2003).
40. Parolari A, Naliato M, Loardi C et al. Surgery of left ventricular aneurysm: a meta-analysis of early outcomes following different reconstruction techniques. Ann. Thorac. Surg. 83(6), 2009-2016 (2007).
41. Abraham WT, Fisher WG, Smith AL et al. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure: N. Engl. J. Med. 346(24), 1845-1853 (2002).
42. Young JB, Abraham WT, Smith AL et al. Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289(20), 2685-2694 (2003).
43. St John Sutton MG, Plappert T, Abraham WT et al. Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107(15), 1985-1990 (2003).
44. Morgan JA, John R, Lee BJ et al. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann. Thorac. Surg. 77(3), 859-863 (2004).
45. Rogers JG, Butler J, Lansman SL, Pierson et al. INTrEPID Investigators. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J. Am. Coll. Cardiol. 50(8), 741-747 (2007).
46. Miller LW, Pagani FD, Russell SD et al. HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N. Engl. J. Med. 357(9), 885-896 (2007).
47. Frazier OH, Gregoric ID, Cohn WE. Initial experience with non-thoracic, extraperitoneal, off-pump insertion of the Jarvik 2000 Heart in patients with previous median sternotomy. J. Heart Lung Transplant. 25(5), 499-503 (2006).
48. Goldstein DJ, Zucker M, Arroyo L et al. Safety and feasibility trial of the MicroMed DeBakey ventricular assist device as a bridge to transplantation. J. Am. Coll. Cardiol. 45(6), 962-963 (2005).
49. Esmore D, Spratt P, Larbalestier R et al. VentrAssist left ventricular assist device: clinical trial results and Clinical Development Plan update. Eur. J. Cardiothorac. Surg. 32(5), 735-744 (2007).
50. Shuhaiber JH, Jenkins D, Berman M et al. The Papworth experience with the Levitronix CentriMag ventricular assist device. J. Heart Lung Transplant. 27(2), 158-164 (2008).
51. Thiele H, Sick P, Boudriot E et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur. Heart J. 26(13), 1276-1283 (2005).
52. Konstam MA, Czerska B, Böhm M et al. Continuous aortic flow augmentation: a pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure. Circulation 112(20), 3107-3114 (2005).
53. Siegenthaler MP, Brehm K, Strecker T et al. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure. A three-center experience. J. Thorac. Cardiovasc. Surg. 127(3), 812-822 (2004).
54. Copeland JG, Smith RG, Arabia FA et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N. Engl. J. Med. 351(9), 859-867 (2004).
55. Dowling RD, Gray LA Jr, Etoch SW et al. Initial experience with the AbioCor implantable replacement heart system. J. Thorac. Cardiovasc. Surg. 127(1), 131-141 (2004).
56. Patel SM, Throckmorton AL, Untaroiu A et al. The status of failure and reliability testing of artificial blood pumps. ASAIO J. 51(4), 440-451 (2005).
57. Sabbah HN. Global left ventricular remodeling with the Acorn Cardiac Support Device: hemodynamic and angiographic findings in dogs with heart failure. Heart Fail. Rev. 10(2), 109-115 (2005).
58. Mann DL, Acker MA, Jessup M et al. Acorn Trial Principal Investigators and Study Coordinators. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Ann. Thorac. Surg. 84(4), 1226-1235 (2007).
59. Acker MA, Bolling S, Shemin R et al. Acorn Trial Principal Investigators and Study Coordinators. Mitral valve surgery in heart failure. Insights from the Acorn Clinical Trial. J. Thorac. Cardiovasc. Surg. 132(3), 568-577 (2006).
60. Starling RC, Jessup M, Oh JK et al. Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial. Ann. Thorac. Surg. 84(4), 1236-1242 (2007).
61. Fukamachi K, McCarthy PM. initial safety and feasibility clinical trial of the myosplint device. J. Card. Surg. 20(6), S43-S47 (2005).
62. Grossi EA, Saunders PC, Woo YJ et al. Intraoperative effects of the coapsys annuloplasty system in a randomized evaluation (RESTOR-MV) of functional ischemic mitral regurgitation. Ann. Thorac. Surg. 80(5), 1706-1711 (2005).
63. Grossi EA, Woo YJ, Schwartz CF et al. Comparison of Coapsys annuloplasty and internal reduction mitral annuloplasty in the randomized treatment of functional ischemic mitral regurgitation: impact on the left ventride. J. Thorac. Cardiovasc. Surg. 131(5), 1095-1098 (2006).
64. Dib N, Michler RE, Pagani FD et al. Safety and feasibitity of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112(12), 1748-1755 (2005).